LIDOCAINE- lidocaine ointment 
Akron Pharma Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

AsperFlex (Lidocaine 4% Ointment)

Active ingredient

Lidocaine HCL 4%

Purpose

Topical Analgesic

Uses

Temporarily relieves minor pain & itching due to:

Warnings

For external use only

Do not use

When using this product

Stop use and ask a doctor if

If pregnant or breast-feeding, ask a health professional before use

Keep out of reach of children and pets. If chewed or swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Other information

Inactive ingredients

aloe vera, mineral oil, petrolatum white, phenoxyethanol, polysorbate 80, purified water.

Questions or comments?

Call toll-free 1-877-255-6999

Childproof Packaging

Tamper Evident: Do not use if imprinted safety seal under cap is broken or missing

Manufactured for:

Akron Pharma Inc.

Fairfield, Nj 07004

Visit at: www.akronpharma.com

Drug Facts

Maximun Strength

NDC 71399-6544-1

AsperFlex™

Touch on Pain

Lidocaine 4% Ointment

Pain reliving Formula

Topical Analgesic

Numbs Away Pain

Made in the USA

NET WT 3.53 OZ (100g)

Lidocaine label

LIDOCAINE 
lidocaine ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71399-6544
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g
Inactive Ingredients
Ingredient NameStrength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
WATER (UNII: 059QF0KO0R)  
MINERAL OIL (UNII: T5L8T28FGP)  
WHITE PETROLATUM (UNII: B6E5W8RQJ4)  
ALOE VERA WHOLE (UNII: KIZ4X2EHYX)  
Product Characteristics
Colorwhite (clear gel) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71399-6544-11 in 1 JAR; Type 0: Not a Combination Product11/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34811/01/2021
Labeler - Akron Pharma Inc. (067878881)

Revised: 4/2023
Document Id: ac5b42b7-854d-40a4-bdde-5345ab594b03
Set id: d22c8c01-1ba2-e9d3-e053-2995a90ac4f0
Version: 2
Effective Time: 20230403
 
Akron Pharma Inc.